SCHEMBL16149264

SCHEMBL16149264

Cc1ccncc1-c1ncccc1F

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.46
CYP11B1 P15538 6/20 0.44
CYP11B2 P19099 6/20 0.44
GABRA1 P14867 3/20 0.44
GABRG2 P18507 3/20 0.44
GABRB3 P28472 3/20 0.44
GABRA5 P31644 3/20 0.44
GABRA3 P34903 3/20 0.44
GPBAR1 Q8TDU6 1/20 0.43
CYP17A1 P05093 7/20 0.40
PTGS2 P35354 1/20 0.40
CYP1A2 P05177 3/20 0.40
TDO2 P48775 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22828751 0.84 CYP2A6 (0.59) CYP2A6CYP11B1CYP11B2GPBAR1CYP17A1
SCHEMBL30546874 0.79 CYP2A6 (0.46) CYP2A6CYP11B1CYP11B2CYP17A1PTGS2
SCHEMBL32667309 0.79 GABRG2 (0.47) CYP2A6CYP11B1CYP11B2GABRA1GABRG2
SCHEMBL20406418 0.77 CYP17A1 (0.47) CYP17A1CYP1A2TDO2
SCHEMBL30444888 0.76 GABRG2 (0.50) CYP2A6GABRA1GABRG2GABRB3GABRA5
SCHEMBL26984944 0.76 GABRG2 (0.42) CYP2A6CYP11B1CYP11B2GABRA1GABRG2
SCHEMBL12497182 0.76 GABRG2 (0.44) CYP2A6GABRA1GABRG2GABRB3GABRA5
Ammonia Solution, Strong SCHEMBL16037372 0.75 GABRG2 (0.49) CYP2A6GABRA1GABRG2GABRB3GABRA5
SCHEMBL15243551 0.74 CYP17A1 (0.44) CYP2A6CYP11B1CYP11B2CYP17A1CYP1A2
SCHEMBL19440910 0.73 CYP17A1 (0.43) CYP2A6CYP11B1CYP11B2CYP17A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970314-A1 SUBSTITUTED 2-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS Janssen Pharmaceutica, N.V. (BE) 2016-01-20 EP claimed
WO-2014165070-A1 SUBSTITUTED 2-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-09 WO claimed